Schedule 13G ownership disclosure
Eleven Biotherapeutics, Inc.
Security class unavailable · CUSIP: 286221106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 11.2520%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-14-002911
- Form type
- SC 13G
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- May 12, 2014
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership